Executive Director, Marketing – Oncology
As a leader on EVERSANA’s oncology team, Christine is leveraging her marketing expertise to guide patients and providers to treatments that can extend patient lives. Her varied experience in pharmaceutical marketing and bank finance provides her with the skills and life sciences knowledge to deliver successful launches and campaigns in today’s competitive global market. Throughout her nine years of marketing experience, she has led oncology marketing efforts for treatments of colorectal cancer, lung cancer, pancreatic cancer, GBM brain cancer and breast cancer. Currently, she focuses on helping patients with metastatic HER2-positive breast cancer through the commercialization of MacroGenics’ MARGENZA™ (margetuximab).
Christine holds a bachelor of science degree in finance and management from State University of New York at Albany and a Master of Business Administration from the University of North Carolina at Chapel Hill.